Open AccessMortality in HIV‐Seropositive versus ‐Seronegative Persons in the Era of Highly Active Antiretroviral Therapy: Implications for When to Initiate Therapy
Author(s) -
Cunlin Wang,
David Vlahov,
Noya Galai,
Joseph Bareta,
Steffanie A. Strathdee,
Kenrad E. Nelson,
Timothy R. Sterling
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/422848
Subject(s) - antiretroviral therapy , medicine , human immunodeficiency virus (hiv) , immunology , virology , viral load
The optimal time to initiate highly active antiretroviral therapy (HAART) remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom